Ombitasvir/paritaprevir/ritonavir/dasabuvir ± ribavirin is safe and effective in HCV‐infected patients in a real‐life cohort from Latin America
暂无分享，去创建一个
M. Mendizabal | M. Silva | A. Soza | E. Aravena | J. Vorobioff | J. Roblero | E. Ridruejo | M. Anders | G. Aballay Soteras | Jhon E. Prieto | A. Muñoz | Daniel Poncino | G. Romero | M. Reggiardo | L. Haddad | A. Varón | Andres Ruf | R. Adrover | N. Hernandez | Mirta Peralta | Roberto Pérez Ravier | M. Cartier | C. Vujacich | F. Gruz | Patricia E Gallardo | A. Ferrada | Daniel Coccozella | Mariano Cartier